Global Drug-Coated Balloons Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Drug-Coated Balloons market size was valued at US$ million in 2023. With growing demand in downstream market, the Drug-Coated Balloons is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Drug-Coated Balloons market. Drug-Coated Balloons are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Drug-Coated Balloons. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Drug-Coated Balloons market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Drug-Coated Balloons market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Drug-Coated Balloons market. It may include historical data, market segmentation by Type (e.g., DCB for Peripheral Artery Disease, DCB for Coronary Artery Disease), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Drug-Coated Balloons market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Drug-Coated Balloons market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Drug-Coated Balloons industry. This include advancements in Drug-Coated Balloons technology, Drug-Coated Balloons new entrants, Drug-Coated Balloons new investment, and other innovations that are shaping the future of Drug-Coated Balloons.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Drug-Coated Balloons market. It includes factors influencing customer ' purchasing decisions, preferences for Drug-Coated Balloons product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Drug-Coated Balloons market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Drug-Coated Balloons market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Drug-Coated Balloons market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Drug-Coated Balloons industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Drug-Coated Balloons market.
Market Segmentation:
Drug-Coated Balloons market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Drug-Coated Balloons market?
What factors are driving Drug-Coated Balloons market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug-Coated Balloons market opportunities vary by end market size?
How does Drug-Coated Balloons break out type, application?
According to our LPI (LP Information) latest study, the global Drug-Coated Balloons market size was valued at US$ million in 2023. With growing demand in downstream market, the Drug-Coated Balloons is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Drug-Coated Balloons market. Drug-Coated Balloons are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Drug-Coated Balloons. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Drug-Coated Balloons market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Drug-Coated Balloons market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Drug-Coated Balloons market. It may include historical data, market segmentation by Type (e.g., DCB for Peripheral Artery Disease, DCB for Coronary Artery Disease), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Drug-Coated Balloons market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Drug-Coated Balloons market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Drug-Coated Balloons industry. This include advancements in Drug-Coated Balloons technology, Drug-Coated Balloons new entrants, Drug-Coated Balloons new investment, and other innovations that are shaping the future of Drug-Coated Balloons.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Drug-Coated Balloons market. It includes factors influencing customer ' purchasing decisions, preferences for Drug-Coated Balloons product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Drug-Coated Balloons market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Drug-Coated Balloons market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Drug-Coated Balloons market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Drug-Coated Balloons industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Drug-Coated Balloons market.
Market Segmentation:
Drug-Coated Balloons market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- DCB for Peripheral Artery Disease
- DCB for Coronary Artery Disease
- DCB for Other Indications
- Hospitals
- Cardiac Catheterization Labs
- ASCs
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medtronic
- BD
- B. Braun Melsungen
- Koninklijke Philips
- Boston Scientific
- Opto Circuits (India)
- Acotec Scientific
- AR Baltic Medical
- Acrostak
- Biosensors International Group
- BioMed
- Concept Medical
- Cardionovum
- Endocor
- Hexacath Sverige
- iVascular SLU
- Minvasys
- MedAlliance
- QT Vascular
- RD Global-Invamed
- SurModics
- Terumo
- Wellinq
What is the 10-year outlook for the global Drug-Coated Balloons market?
What factors are driving Drug-Coated Balloons market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug-Coated Balloons market opportunities vary by end market size?
How does Drug-Coated Balloons break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug-Coated Balloons Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Drug-Coated Balloons by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Drug-Coated Balloons by Country/Region, 2019, 2023 & 2030
2.2 Drug-Coated Balloons Segment by Type
2.2.1 DCB for Peripheral Artery Disease
2.2.2 DCB for Coronary Artery Disease
2.2.3 DCB for Other Indications
2.3 Drug-Coated Balloons Sales by Type
2.3.1 Global Drug-Coated Balloons Sales Market Share by Type (2019-2024)
2.3.2 Global Drug-Coated Balloons Revenue and Market Share by Type (2019-2024)
2.3.3 Global Drug-Coated Balloons Sale Price by Type (2019-2024)
2.4 Drug-Coated Balloons Segment by Application
2.4.1 Hospitals
2.4.2 Cardiac Catheterization Labs
2.4.3 ASCs
2.5 Drug-Coated Balloons Sales by Application
2.5.1 Global Drug-Coated Balloons Sale Market Share by Application (2019-2024)
2.5.2 Global Drug-Coated Balloons Revenue and Market Share by Application (2019-2024)
2.5.3 Global Drug-Coated Balloons Sale Price by Application (2019-2024)
3 GLOBAL DRUG-COATED BALLOONS BY COMPANY
3.1 Global Drug-Coated Balloons Breakdown Data by Company
3.1.1 Global Drug-Coated Balloons Annual Sales by Company (2019-2024)
3.1.2 Global Drug-Coated Balloons Sales Market Share by Company (2019-2024)
3.2 Global Drug-Coated Balloons Annual Revenue by Company (2019-2024)
3.2.1 Global Drug-Coated Balloons Revenue by Company (2019-2024)
3.2.2 Global Drug-Coated Balloons Revenue Market Share by Company (2019-2024)
3.3 Global Drug-Coated Balloons Sale Price by Company
3.4 Key Manufacturers Drug-Coated Balloons Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug-Coated Balloons Product Location Distribution
3.4.2 Players Drug-Coated Balloons Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DRUG-COATED BALLOONS BY GEOGRAPHIC REGION
4.1 World Historic Drug-Coated Balloons Market Size by Geographic Region (2019-2024)
4.1.1 Global Drug-Coated Balloons Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Drug-Coated Balloons Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Drug-Coated Balloons Market Size by Country/Region (2019-2024)
4.2.1 Global Drug-Coated Balloons Annual Sales by Country/Region (2019-2024)
4.2.2 Global Drug-Coated Balloons Annual Revenue by Country/Region (2019-2024)
4.3 Americas Drug-Coated Balloons Sales Growth
4.4 APAC Drug-Coated Balloons Sales Growth
4.5 Europe Drug-Coated Balloons Sales Growth
4.6 Middle East & Africa Drug-Coated Balloons Sales Growth
5 AMERICAS
5.1 Americas Drug-Coated Balloons Sales by Country
5.1.1 Americas Drug-Coated Balloons Sales by Country (2019-2024)
5.1.2 Americas Drug-Coated Balloons Revenue by Country (2019-2024)
5.2 Americas Drug-Coated Balloons Sales by Type
5.3 Americas Drug-Coated Balloons Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug-Coated Balloons Sales by Region
6.1.1 APAC Drug-Coated Balloons Sales by Region (2019-2024)
6.1.2 APAC Drug-Coated Balloons Revenue by Region (2019-2024)
6.2 APAC Drug-Coated Balloons Sales by Type
6.3 APAC Drug-Coated Balloons Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug-Coated Balloons by Country
7.1.1 Europe Drug-Coated Balloons Sales by Country (2019-2024)
7.1.2 Europe Drug-Coated Balloons Revenue by Country (2019-2024)
7.2 Europe Drug-Coated Balloons Sales by Type
7.3 Europe Drug-Coated Balloons Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug-Coated Balloons by Country
8.1.1 Middle East & Africa Drug-Coated Balloons Sales by Country (2019-2024)
8.1.2 Middle East & Africa Drug-Coated Balloons Revenue by Country (2019-2024)
8.2 Middle East & Africa Drug-Coated Balloons Sales by Type
8.3 Middle East & Africa Drug-Coated Balloons Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug-Coated Balloons
10.3 Manufacturing Process Analysis of Drug-Coated Balloons
10.4 Industry Chain Structure of Drug-Coated Balloons
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug-Coated Balloons Distributors
11.3 Drug-Coated Balloons Customer
12 WORLD FORECAST REVIEW FOR DRUG-COATED BALLOONS BY GEOGRAPHIC REGION
12.1 Global Drug-Coated Balloons Market Size Forecast by Region
12.1.1 Global Drug-Coated Balloons Forecast by Region (2025-2030)
12.1.2 Global Drug-Coated Balloons Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug-Coated Balloons Forecast by Type
12.7 Global Drug-Coated Balloons Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Drug-Coated Balloons Product Portfolios and Specifications
13.1.3 Medtronic Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 BD
13.2.1 BD Company Information
13.2.2 BD Drug-Coated Balloons Product Portfolios and Specifications
13.2.3 BD Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 BD Main Business Overview
13.2.5 BD Latest Developments
13.3 B. Braun Melsungen
13.3.1 B. Braun Melsungen Company Information
13.3.2 B. Braun Melsungen Drug-Coated Balloons Product Portfolios and Specifications
13.3.3 B. Braun Melsungen Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 B. Braun Melsungen Main Business Overview
13.3.5 B. Braun Melsungen Latest Developments
13.4 Koninklijke Philips
13.4.1 Koninklijke Philips Company Information
13.4.2 Koninklijke Philips Drug-Coated Balloons Product Portfolios and Specifications
13.4.3 Koninklijke Philips Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Koninklijke Philips Main Business Overview
13.4.5 Koninklijke Philips Latest Developments
13.5 Boston Scientific
13.5.1 Boston Scientific Company Information
13.5.2 Boston Scientific Drug-Coated Balloons Product Portfolios and Specifications
13.5.3 Boston Scientific Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Boston Scientific Main Business Overview
13.5.5 Boston Scientific Latest Developments
13.6 Opto Circuits (India)
13.6.1 Opto Circuits (India) Company Information
13.6.2 Opto Circuits (India) Drug-Coated Balloons Product Portfolios and Specifications
13.6.3 Opto Circuits (India) Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Opto Circuits (India) Main Business Overview
13.6.5 Opto Circuits (India) Latest Developments
13.7 Acotec Scientific
13.7.1 Acotec Scientific Company Information
13.7.2 Acotec Scientific Drug-Coated Balloons Product Portfolios and Specifications
13.7.3 Acotec Scientific Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Acotec Scientific Main Business Overview
13.7.5 Acotec Scientific Latest Developments
13.8 AR Baltic Medical
13.8.1 AR Baltic Medical Company Information
13.8.2 AR Baltic Medical Drug-Coated Balloons Product Portfolios and Specifications
13.8.3 AR Baltic Medical Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 AR Baltic Medical Main Business Overview
13.8.5 AR Baltic Medical Latest Developments
13.9 Acrostak
13.9.1 Acrostak Company Information
13.9.2 Acrostak Drug-Coated Balloons Product Portfolios and Specifications
13.9.3 Acrostak Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Acrostak Main Business Overview
13.9.5 Acrostak Latest Developments
13.10 Biosensors International Group
13.10.1 Biosensors International Group Company Information
13.10.2 Biosensors International Group Drug-Coated Balloons Product Portfolios and Specifications
13.10.3 Biosensors International Group Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Biosensors International Group Main Business Overview
13.10.5 Biosensors International Group Latest Developments
13.11 BioMed
13.11.1 BioMed Company Information
13.11.2 BioMed Drug-Coated Balloons Product Portfolios and Specifications
13.11.3 BioMed Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 BioMed Main Business Overview
13.11.5 BioMed Latest Developments
13.12 Concept Medical
13.12.1 Concept Medical Company Information
13.12.2 Concept Medical Drug-Coated Balloons Product Portfolios and Specifications
13.12.3 Concept Medical Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Concept Medical Main Business Overview
13.12.5 Concept Medical Latest Developments
13.13 Cardionovum
13.13.1 Cardionovum Company Information
13.13.2 Cardionovum Drug-Coated Balloons Product Portfolios and Specifications
13.13.3 Cardionovum Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Cardionovum Main Business Overview
13.13.5 Cardionovum Latest Developments
13.14 Endocor
13.14.1 Endocor Company Information
13.14.2 Endocor Drug-Coated Balloons Product Portfolios and Specifications
13.14.3 Endocor Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Endocor Main Business Overview
13.14.5 Endocor Latest Developments
13.15 Hexacath Sverige
13.15.1 Hexacath Sverige Company Information
13.15.2 Hexacath Sverige Drug-Coated Balloons Product Portfolios and Specifications
13.15.3 Hexacath Sverige Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Hexacath Sverige Main Business Overview
13.15.5 Hexacath Sverige Latest Developments
13.16 iVascular SLU
13.16.1 iVascular SLU Company Information
13.16.2 iVascular SLU Drug-Coated Balloons Product Portfolios and Specifications
13.16.3 iVascular SLU Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 iVascular SLU Main Business Overview
13.16.5 iVascular SLU Latest Developments
13.17 Minvasys
13.17.1 Minvasys Company Information
13.17.2 Minvasys Drug-Coated Balloons Product Portfolios and Specifications
13.17.3 Minvasys Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Minvasys Main Business Overview
13.17.5 Minvasys Latest Developments
13.18 MedAlliance
13.18.1 MedAlliance Company Information
13.18.2 MedAlliance Drug-Coated Balloons Product Portfolios and Specifications
13.18.3 MedAlliance Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 MedAlliance Main Business Overview
13.18.5 MedAlliance Latest Developments
13.19 QT Vascular
13.19.1 QT Vascular Company Information
13.19.2 QT Vascular Drug-Coated Balloons Product Portfolios and Specifications
13.19.3 QT Vascular Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 QT Vascular Main Business Overview
13.19.5 QT Vascular Latest Developments
13.20 RD Global-Invamed
13.20.1 RD Global-Invamed Company Information
13.20.2 RD Global-Invamed Drug-Coated Balloons Product Portfolios and Specifications
13.20.3 RD Global-Invamed Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 RD Global-Invamed Main Business Overview
13.20.5 RD Global-Invamed Latest Developments
13.21 SurModics
13.21.1 SurModics Company Information
13.21.2 SurModics Drug-Coated Balloons Product Portfolios and Specifications
13.21.3 SurModics Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 SurModics Main Business Overview
13.21.5 SurModics Latest Developments
13.22 Terumo
13.22.1 Terumo Company Information
13.22.2 Terumo Drug-Coated Balloons Product Portfolios and Specifications
13.22.3 Terumo Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 Terumo Main Business Overview
13.22.5 Terumo Latest Developments
13.23 Wellinq
13.23.1 Wellinq Company Information
13.23.2 Wellinq Drug-Coated Balloons Product Portfolios and Specifications
13.23.3 Wellinq Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.23.4 Wellinq Main Business Overview
13.23.5 Wellinq Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug-Coated Balloons Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Drug-Coated Balloons by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Drug-Coated Balloons by Country/Region, 2019, 2023 & 2030
2.2 Drug-Coated Balloons Segment by Type
2.2.1 DCB for Peripheral Artery Disease
2.2.2 DCB for Coronary Artery Disease
2.2.3 DCB for Other Indications
2.3 Drug-Coated Balloons Sales by Type
2.3.1 Global Drug-Coated Balloons Sales Market Share by Type (2019-2024)
2.3.2 Global Drug-Coated Balloons Revenue and Market Share by Type (2019-2024)
2.3.3 Global Drug-Coated Balloons Sale Price by Type (2019-2024)
2.4 Drug-Coated Balloons Segment by Application
2.4.1 Hospitals
2.4.2 Cardiac Catheterization Labs
2.4.3 ASCs
2.5 Drug-Coated Balloons Sales by Application
2.5.1 Global Drug-Coated Balloons Sale Market Share by Application (2019-2024)
2.5.2 Global Drug-Coated Balloons Revenue and Market Share by Application (2019-2024)
2.5.3 Global Drug-Coated Balloons Sale Price by Application (2019-2024)
3 GLOBAL DRUG-COATED BALLOONS BY COMPANY
3.1 Global Drug-Coated Balloons Breakdown Data by Company
3.1.1 Global Drug-Coated Balloons Annual Sales by Company (2019-2024)
3.1.2 Global Drug-Coated Balloons Sales Market Share by Company (2019-2024)
3.2 Global Drug-Coated Balloons Annual Revenue by Company (2019-2024)
3.2.1 Global Drug-Coated Balloons Revenue by Company (2019-2024)
3.2.2 Global Drug-Coated Balloons Revenue Market Share by Company (2019-2024)
3.3 Global Drug-Coated Balloons Sale Price by Company
3.4 Key Manufacturers Drug-Coated Balloons Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug-Coated Balloons Product Location Distribution
3.4.2 Players Drug-Coated Balloons Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DRUG-COATED BALLOONS BY GEOGRAPHIC REGION
4.1 World Historic Drug-Coated Balloons Market Size by Geographic Region (2019-2024)
4.1.1 Global Drug-Coated Balloons Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Drug-Coated Balloons Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Drug-Coated Balloons Market Size by Country/Region (2019-2024)
4.2.1 Global Drug-Coated Balloons Annual Sales by Country/Region (2019-2024)
4.2.2 Global Drug-Coated Balloons Annual Revenue by Country/Region (2019-2024)
4.3 Americas Drug-Coated Balloons Sales Growth
4.4 APAC Drug-Coated Balloons Sales Growth
4.5 Europe Drug-Coated Balloons Sales Growth
4.6 Middle East & Africa Drug-Coated Balloons Sales Growth
5 AMERICAS
5.1 Americas Drug-Coated Balloons Sales by Country
5.1.1 Americas Drug-Coated Balloons Sales by Country (2019-2024)
5.1.2 Americas Drug-Coated Balloons Revenue by Country (2019-2024)
5.2 Americas Drug-Coated Balloons Sales by Type
5.3 Americas Drug-Coated Balloons Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug-Coated Balloons Sales by Region
6.1.1 APAC Drug-Coated Balloons Sales by Region (2019-2024)
6.1.2 APAC Drug-Coated Balloons Revenue by Region (2019-2024)
6.2 APAC Drug-Coated Balloons Sales by Type
6.3 APAC Drug-Coated Balloons Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug-Coated Balloons by Country
7.1.1 Europe Drug-Coated Balloons Sales by Country (2019-2024)
7.1.2 Europe Drug-Coated Balloons Revenue by Country (2019-2024)
7.2 Europe Drug-Coated Balloons Sales by Type
7.3 Europe Drug-Coated Balloons Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug-Coated Balloons by Country
8.1.1 Middle East & Africa Drug-Coated Balloons Sales by Country (2019-2024)
8.1.2 Middle East & Africa Drug-Coated Balloons Revenue by Country (2019-2024)
8.2 Middle East & Africa Drug-Coated Balloons Sales by Type
8.3 Middle East & Africa Drug-Coated Balloons Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug-Coated Balloons
10.3 Manufacturing Process Analysis of Drug-Coated Balloons
10.4 Industry Chain Structure of Drug-Coated Balloons
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug-Coated Balloons Distributors
11.3 Drug-Coated Balloons Customer
12 WORLD FORECAST REVIEW FOR DRUG-COATED BALLOONS BY GEOGRAPHIC REGION
12.1 Global Drug-Coated Balloons Market Size Forecast by Region
12.1.1 Global Drug-Coated Balloons Forecast by Region (2025-2030)
12.1.2 Global Drug-Coated Balloons Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug-Coated Balloons Forecast by Type
12.7 Global Drug-Coated Balloons Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Drug-Coated Balloons Product Portfolios and Specifications
13.1.3 Medtronic Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 BD
13.2.1 BD Company Information
13.2.2 BD Drug-Coated Balloons Product Portfolios and Specifications
13.2.3 BD Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 BD Main Business Overview
13.2.5 BD Latest Developments
13.3 B. Braun Melsungen
13.3.1 B. Braun Melsungen Company Information
13.3.2 B. Braun Melsungen Drug-Coated Balloons Product Portfolios and Specifications
13.3.3 B. Braun Melsungen Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 B. Braun Melsungen Main Business Overview
13.3.5 B. Braun Melsungen Latest Developments
13.4 Koninklijke Philips
13.4.1 Koninklijke Philips Company Information
13.4.2 Koninklijke Philips Drug-Coated Balloons Product Portfolios and Specifications
13.4.3 Koninklijke Philips Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Koninklijke Philips Main Business Overview
13.4.5 Koninklijke Philips Latest Developments
13.5 Boston Scientific
13.5.1 Boston Scientific Company Information
13.5.2 Boston Scientific Drug-Coated Balloons Product Portfolios and Specifications
13.5.3 Boston Scientific Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Boston Scientific Main Business Overview
13.5.5 Boston Scientific Latest Developments
13.6 Opto Circuits (India)
13.6.1 Opto Circuits (India) Company Information
13.6.2 Opto Circuits (India) Drug-Coated Balloons Product Portfolios and Specifications
13.6.3 Opto Circuits (India) Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Opto Circuits (India) Main Business Overview
13.6.5 Opto Circuits (India) Latest Developments
13.7 Acotec Scientific
13.7.1 Acotec Scientific Company Information
13.7.2 Acotec Scientific Drug-Coated Balloons Product Portfolios and Specifications
13.7.3 Acotec Scientific Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Acotec Scientific Main Business Overview
13.7.5 Acotec Scientific Latest Developments
13.8 AR Baltic Medical
13.8.1 AR Baltic Medical Company Information
13.8.2 AR Baltic Medical Drug-Coated Balloons Product Portfolios and Specifications
13.8.3 AR Baltic Medical Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 AR Baltic Medical Main Business Overview
13.8.5 AR Baltic Medical Latest Developments
13.9 Acrostak
13.9.1 Acrostak Company Information
13.9.2 Acrostak Drug-Coated Balloons Product Portfolios and Specifications
13.9.3 Acrostak Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Acrostak Main Business Overview
13.9.5 Acrostak Latest Developments
13.10 Biosensors International Group
13.10.1 Biosensors International Group Company Information
13.10.2 Biosensors International Group Drug-Coated Balloons Product Portfolios and Specifications
13.10.3 Biosensors International Group Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Biosensors International Group Main Business Overview
13.10.5 Biosensors International Group Latest Developments
13.11 BioMed
13.11.1 BioMed Company Information
13.11.2 BioMed Drug-Coated Balloons Product Portfolios and Specifications
13.11.3 BioMed Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 BioMed Main Business Overview
13.11.5 BioMed Latest Developments
13.12 Concept Medical
13.12.1 Concept Medical Company Information
13.12.2 Concept Medical Drug-Coated Balloons Product Portfolios and Specifications
13.12.3 Concept Medical Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Concept Medical Main Business Overview
13.12.5 Concept Medical Latest Developments
13.13 Cardionovum
13.13.1 Cardionovum Company Information
13.13.2 Cardionovum Drug-Coated Balloons Product Portfolios and Specifications
13.13.3 Cardionovum Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Cardionovum Main Business Overview
13.13.5 Cardionovum Latest Developments
13.14 Endocor
13.14.1 Endocor Company Information
13.14.2 Endocor Drug-Coated Balloons Product Portfolios and Specifications
13.14.3 Endocor Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Endocor Main Business Overview
13.14.5 Endocor Latest Developments
13.15 Hexacath Sverige
13.15.1 Hexacath Sverige Company Information
13.15.2 Hexacath Sverige Drug-Coated Balloons Product Portfolios and Specifications
13.15.3 Hexacath Sverige Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Hexacath Sverige Main Business Overview
13.15.5 Hexacath Sverige Latest Developments
13.16 iVascular SLU
13.16.1 iVascular SLU Company Information
13.16.2 iVascular SLU Drug-Coated Balloons Product Portfolios and Specifications
13.16.3 iVascular SLU Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 iVascular SLU Main Business Overview
13.16.5 iVascular SLU Latest Developments
13.17 Minvasys
13.17.1 Minvasys Company Information
13.17.2 Minvasys Drug-Coated Balloons Product Portfolios and Specifications
13.17.3 Minvasys Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Minvasys Main Business Overview
13.17.5 Minvasys Latest Developments
13.18 MedAlliance
13.18.1 MedAlliance Company Information
13.18.2 MedAlliance Drug-Coated Balloons Product Portfolios and Specifications
13.18.3 MedAlliance Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 MedAlliance Main Business Overview
13.18.5 MedAlliance Latest Developments
13.19 QT Vascular
13.19.1 QT Vascular Company Information
13.19.2 QT Vascular Drug-Coated Balloons Product Portfolios and Specifications
13.19.3 QT Vascular Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 QT Vascular Main Business Overview
13.19.5 QT Vascular Latest Developments
13.20 RD Global-Invamed
13.20.1 RD Global-Invamed Company Information
13.20.2 RD Global-Invamed Drug-Coated Balloons Product Portfolios and Specifications
13.20.3 RD Global-Invamed Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 RD Global-Invamed Main Business Overview
13.20.5 RD Global-Invamed Latest Developments
13.21 SurModics
13.21.1 SurModics Company Information
13.21.2 SurModics Drug-Coated Balloons Product Portfolios and Specifications
13.21.3 SurModics Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 SurModics Main Business Overview
13.21.5 SurModics Latest Developments
13.22 Terumo
13.22.1 Terumo Company Information
13.22.2 Terumo Drug-Coated Balloons Product Portfolios and Specifications
13.22.3 Terumo Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 Terumo Main Business Overview
13.22.5 Terumo Latest Developments
13.23 Wellinq
13.23.1 Wellinq Company Information
13.23.2 Wellinq Drug-Coated Balloons Product Portfolios and Specifications
13.23.3 Wellinq Drug-Coated Balloons Sales, Revenue, Price and Gross Margin (2019-2024)
13.23.4 Wellinq Main Business Overview
13.23.5 Wellinq Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drug-Coated Balloons Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Drug-Coated Balloons Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of DCB for Peripheral Artery Disease
Table 4. Major Players of DCB for Coronary Artery Disease
Table 5. Major Players of DCB for Other Indications
Table 6. Global Drug-Coated Balloons Sales by Type (2019-2024) & (K Units)
Table 7. Global Drug-Coated Balloons Sales Market Share by Type (2019-2024)
Table 8. Global Drug-Coated Balloons Revenue by Type (2019-2024) & ($ million)
Table 9. Global Drug-Coated Balloons Revenue Market Share by Type (2019-2024)
Table 10. Global Drug-Coated Balloons Sale Price by Type (2019-2024) & (USD/Unit)
Table 11. Global Drug-Coated Balloons Sales by Application (2019-2024) & (K Units)
Table 12. Global Drug-Coated Balloons Sales Market Share by Application (2019-2024)
Table 13. Global Drug-Coated Balloons Revenue by Application (2019-2024)
Table 14. Global Drug-Coated Balloons Revenue Market Share by Application (2019-2024)
Table 15. Global Drug-Coated Balloons Sale Price by Application (2019-2024) & (USD/Unit)
Table 16. Global Drug-Coated Balloons Sales by Company (2019-2024) & (K Units)
Table 17. Global Drug-Coated Balloons Sales Market Share by Company (2019-2024)
Table 18. Global Drug-Coated Balloons Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Drug-Coated Balloons Revenue Market Share by Company (2019-2024)
Table 20. Global Drug-Coated Balloons Sale Price by Company (2019-2024) & (USD/Unit)
Table 21. Key Manufacturers Drug-Coated Balloons Producing Area Distribution and Sales Area
Table 22. Players Drug-Coated Balloons Products Offered
Table 23. Drug-Coated Balloons Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Drug-Coated Balloons Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Drug-Coated Balloons Sales Market Share Geographic Region (2019-2024)
Table 28. Global Drug-Coated Balloons Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Drug-Coated Balloons Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Drug-Coated Balloons Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Drug-Coated Balloons Sales Market Share by Country/Region (2019-2024)
Table 32. Global Drug-Coated Balloons Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Drug-Coated Balloons Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Drug-Coated Balloons Sales by Country (2019-2024) & (K Units)
Table 35. Americas Drug-Coated Balloons Sales Market Share by Country (2019-2024)
Table 36. Americas Drug-Coated Balloons Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Drug-Coated Balloons Revenue Market Share by Country (2019-2024)
Table 38. Americas Drug-Coated Balloons Sales by Type (2019-2024) & (K Units)
Table 39. Americas Drug-Coated Balloons Sales by Application (2019-2024) & (K Units)
Table 40. APAC Drug-Coated Balloons Sales by Region (2019-2024) & (K Units)
Table 41. APAC Drug-Coated Balloons Sales Market Share by Region (2019-2024)
Table 42. APAC Drug-Coated Balloons Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Drug-Coated Balloons Revenue Market Share by Region (2019-2024)
Table 44. APAC Drug-Coated Balloons Sales by Type (2019-2024) & (K Units)
Table 45. APAC Drug-Coated Balloons Sales by Application (2019-2024) & (K Units)
Table 46. Europe Drug-Coated Balloons Sales by Country (2019-2024) & (K Units)
Table 47. Europe Drug-Coated Balloons Sales Market Share by Country (2019-2024)
Table 48. Europe Drug-Coated Balloons Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Drug-Coated Balloons Revenue Market Share by Country (2019-2024)
Table 50. Europe Drug-Coated Balloons Sales by Type (2019-2024) & (K Units)
Table 51. Europe Drug-Coated Balloons Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Drug-Coated Balloons Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Drug-Coated Balloons Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Drug-Coated Balloons Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Drug-Coated Balloons Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Drug-Coated Balloons Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Drug-Coated Balloons Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Drug-Coated Balloons
Table 59. Key Market Challenges & Risks of Drug-Coated Balloons
Table 60. Key Industry Trends of Drug-Coated Balloons
Table 61. Drug-Coated Balloons Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Drug-Coated Balloons Distributors List
Table 64. Drug-Coated Balloons Customer List
Table 65. Global Drug-Coated Balloons Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Drug-Coated Balloons Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Drug-Coated Balloons Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Drug-Coated Balloons Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Drug-Coated Balloons Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Drug-Coated Balloons Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Drug-Coated Balloons Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Drug-Coated Balloons Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Drug-Coated Balloons Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Drug-Coated Balloons Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Drug-Coated Balloons Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Drug-Coated Balloons Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Drug-Coated Balloons Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Drug-Coated Balloons Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Medtronic Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 80. Medtronic Drug-Coated Balloons Product Portfolios and Specifications
Table 81. Medtronic Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Medtronic Main Business
Table 83. Medtronic Latest Developments
Table 84. BD Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 85. BD Drug-Coated Balloons Product Portfolios and Specifications
Table 86. BD Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. BD Main Business
Table 88. BD Latest Developments
Table 89. B. Braun Melsungen Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 90. B. Braun Melsungen Drug-Coated Balloons Product Portfolios and Specifications
Table 91. B. Braun Melsungen Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. B. Braun Melsungen Main Business
Table 93. B. Braun Melsungen Latest Developments
Table 94. Koninklijke Philips Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 95. Koninklijke Philips Drug-Coated Balloons Product Portfolios and Specifications
Table 96. Koninklijke Philips Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Koninklijke Philips Main Business
Table 98. Koninklijke Philips Latest Developments
Table 99. Boston Scientific Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 100. Boston Scientific Drug-Coated Balloons Product Portfolios and Specifications
Table 101. Boston Scientific Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Boston Scientific Main Business
Table 103. Boston Scientific Latest Developments
Table 104. Opto Circuits (India) Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 105. Opto Circuits (India) Drug-Coated Balloons Product Portfolios and Specifications
Table 106. Opto Circuits (India) Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Opto Circuits (India) Main Business
Table 108. Opto Circuits (India) Latest Developments
Table 109. Acotec Scientific Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 110. Acotec Scientific Drug-Coated Balloons Product Portfolios and Specifications
Table 111. Acotec Scientific Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Acotec Scientific Main Business
Table 113. Acotec Scientific Latest Developments
Table 114. AR Baltic Medical Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 115. AR Baltic Medical Drug-Coated Balloons Product Portfolios and Specifications
Table 116. AR Baltic Medical Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. AR Baltic Medical Main Business
Table 118. AR Baltic Medical Latest Developments
Table 119. Acrostak Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 120. Acrostak Drug-Coated Balloons Product Portfolios and Specifications
Table 121. Acrostak Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Acrostak Main Business
Table 123. Acrostak Latest Developments
Table 124. Biosensors International Group Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 125. Biosensors International Group Drug-Coated Balloons Product Portfolios and Specifications
Table 126. Biosensors International Group Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. Biosensors International Group Main Business
Table 128. Biosensors International Group Latest Developments
Table 129. BioMed Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 130. BioMed Drug-Coated Balloons Product Portfolios and Specifications
Table 131. BioMed Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. BioMed Main Business
Table 133. BioMed Latest Developments
Table 134. Concept Medical Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 135. Concept Medical Drug-Coated Balloons Product Portfolios and Specifications
Table 136. Concept Medical Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 137. Concept Medical Main Business
Table 138. Concept Medical Latest Developments
Table 139. Cardionovum Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 140. Cardionovum Drug-Coated Balloons Product Portfolios and Specifications
Table 141. Cardionovum Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 142. Cardionovum Main Business
Table 143. Cardionovum Latest Developments
Table 144. Endocor Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 145. Endocor Drug-Coated Balloons Product Portfolios and Specifications
Table 146. Endocor Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 147. Endocor Main Business
Table 148. Endocor Latest Developments
Table 149. Hexacath Sverige Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 150. Hexacath Sverige Drug-Coated Balloons Product Portfolios and Specifications
Table 151. Hexacath Sverige Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 152. Hexacath Sverige Main Business
Table 153. Hexacath Sverige Latest Developments
Table 154. iVascular SLU Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 155. iVascular SLU Drug-Coated Balloons Product Portfolios and Specifications
Table 156. iVascular SLU Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 157. iVascular SLU Main Business
Table 158. iVascular SLU Latest Developments
Table 159. Minvasys Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 160. Minvasys Drug-Coated Balloons Product Portfolios and Specifications
Table 161. Minvasys Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 162. Minvasys Main Business
Table 163. Minvasys Latest Developments
Table 164. MedAlliance Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 165. MedAlliance Drug-Coated Balloons Product Portfolios and Specifications
Table 166. MedAlliance Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 167. MedAlliance Main Business
Table 168. MedAlliance Latest Developments
Table 169. QT Vascular Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 170. QT Vascular Drug-Coated Balloons Product Portfolios and Specifications
Table 171. QT Vascular Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 172. QT Vascular Main Business
Table 173. QT Vascular Latest Developments
Table 174. RD Global-Invamed Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 175. RD Global-Invamed Drug-Coated Balloons Product Portfolios and Specifications
Table 176. RD Global-Invamed Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 177. RD Global-Invamed Main Business
Table 178. RD Global-Invamed Latest Developments
Table 179. SurModics Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 180. SurModics Drug-Coated Balloons Product Portfolios and Specifications
Table 181. SurModics Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 182. SurModics Main Business
Table 183. SurModics Latest Developments
Table 184. Terumo Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 185. Terumo Drug-Coated Balloons Product Portfolios and Specifications
Table 186. Terumo Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 187. Terumo Main Business
Table 188. Terumo Latest Developments
Table 189. Wellinq Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 190. Wellinq Drug-Coated Balloons Product Portfolios and Specifications
Table 191. Wellinq Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 192. Wellinq Main Business
Table 193. Wellinq Latest Developments
Table 1. Drug-Coated Balloons Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Drug-Coated Balloons Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of DCB for Peripheral Artery Disease
Table 4. Major Players of DCB for Coronary Artery Disease
Table 5. Major Players of DCB for Other Indications
Table 6. Global Drug-Coated Balloons Sales by Type (2019-2024) & (K Units)
Table 7. Global Drug-Coated Balloons Sales Market Share by Type (2019-2024)
Table 8. Global Drug-Coated Balloons Revenue by Type (2019-2024) & ($ million)
Table 9. Global Drug-Coated Balloons Revenue Market Share by Type (2019-2024)
Table 10. Global Drug-Coated Balloons Sale Price by Type (2019-2024) & (USD/Unit)
Table 11. Global Drug-Coated Balloons Sales by Application (2019-2024) & (K Units)
Table 12. Global Drug-Coated Balloons Sales Market Share by Application (2019-2024)
Table 13. Global Drug-Coated Balloons Revenue by Application (2019-2024)
Table 14. Global Drug-Coated Balloons Revenue Market Share by Application (2019-2024)
Table 15. Global Drug-Coated Balloons Sale Price by Application (2019-2024) & (USD/Unit)
Table 16. Global Drug-Coated Balloons Sales by Company (2019-2024) & (K Units)
Table 17. Global Drug-Coated Balloons Sales Market Share by Company (2019-2024)
Table 18. Global Drug-Coated Balloons Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Drug-Coated Balloons Revenue Market Share by Company (2019-2024)
Table 20. Global Drug-Coated Balloons Sale Price by Company (2019-2024) & (USD/Unit)
Table 21. Key Manufacturers Drug-Coated Balloons Producing Area Distribution and Sales Area
Table 22. Players Drug-Coated Balloons Products Offered
Table 23. Drug-Coated Balloons Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Drug-Coated Balloons Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Drug-Coated Balloons Sales Market Share Geographic Region (2019-2024)
Table 28. Global Drug-Coated Balloons Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Drug-Coated Balloons Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Drug-Coated Balloons Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Drug-Coated Balloons Sales Market Share by Country/Region (2019-2024)
Table 32. Global Drug-Coated Balloons Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Drug-Coated Balloons Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Drug-Coated Balloons Sales by Country (2019-2024) & (K Units)
Table 35. Americas Drug-Coated Balloons Sales Market Share by Country (2019-2024)
Table 36. Americas Drug-Coated Balloons Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Drug-Coated Balloons Revenue Market Share by Country (2019-2024)
Table 38. Americas Drug-Coated Balloons Sales by Type (2019-2024) & (K Units)
Table 39. Americas Drug-Coated Balloons Sales by Application (2019-2024) & (K Units)
Table 40. APAC Drug-Coated Balloons Sales by Region (2019-2024) & (K Units)
Table 41. APAC Drug-Coated Balloons Sales Market Share by Region (2019-2024)
Table 42. APAC Drug-Coated Balloons Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Drug-Coated Balloons Revenue Market Share by Region (2019-2024)
Table 44. APAC Drug-Coated Balloons Sales by Type (2019-2024) & (K Units)
Table 45. APAC Drug-Coated Balloons Sales by Application (2019-2024) & (K Units)
Table 46. Europe Drug-Coated Balloons Sales by Country (2019-2024) & (K Units)
Table 47. Europe Drug-Coated Balloons Sales Market Share by Country (2019-2024)
Table 48. Europe Drug-Coated Balloons Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Drug-Coated Balloons Revenue Market Share by Country (2019-2024)
Table 50. Europe Drug-Coated Balloons Sales by Type (2019-2024) & (K Units)
Table 51. Europe Drug-Coated Balloons Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Drug-Coated Balloons Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Drug-Coated Balloons Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Drug-Coated Balloons Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Drug-Coated Balloons Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Drug-Coated Balloons Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Drug-Coated Balloons Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Drug-Coated Balloons
Table 59. Key Market Challenges & Risks of Drug-Coated Balloons
Table 60. Key Industry Trends of Drug-Coated Balloons
Table 61. Drug-Coated Balloons Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Drug-Coated Balloons Distributors List
Table 64. Drug-Coated Balloons Customer List
Table 65. Global Drug-Coated Balloons Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Drug-Coated Balloons Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Drug-Coated Balloons Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Drug-Coated Balloons Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Drug-Coated Balloons Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Drug-Coated Balloons Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Drug-Coated Balloons Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Drug-Coated Balloons Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Drug-Coated Balloons Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Drug-Coated Balloons Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Drug-Coated Balloons Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Drug-Coated Balloons Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Drug-Coated Balloons Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Drug-Coated Balloons Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Medtronic Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 80. Medtronic Drug-Coated Balloons Product Portfolios and Specifications
Table 81. Medtronic Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Medtronic Main Business
Table 83. Medtronic Latest Developments
Table 84. BD Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 85. BD Drug-Coated Balloons Product Portfolios and Specifications
Table 86. BD Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. BD Main Business
Table 88. BD Latest Developments
Table 89. B. Braun Melsungen Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 90. B. Braun Melsungen Drug-Coated Balloons Product Portfolios and Specifications
Table 91. B. Braun Melsungen Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. B. Braun Melsungen Main Business
Table 93. B. Braun Melsungen Latest Developments
Table 94. Koninklijke Philips Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 95. Koninklijke Philips Drug-Coated Balloons Product Portfolios and Specifications
Table 96. Koninklijke Philips Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Koninklijke Philips Main Business
Table 98. Koninklijke Philips Latest Developments
Table 99. Boston Scientific Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 100. Boston Scientific Drug-Coated Balloons Product Portfolios and Specifications
Table 101. Boston Scientific Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Boston Scientific Main Business
Table 103. Boston Scientific Latest Developments
Table 104. Opto Circuits (India) Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 105. Opto Circuits (India) Drug-Coated Balloons Product Portfolios and Specifications
Table 106. Opto Circuits (India) Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Opto Circuits (India) Main Business
Table 108. Opto Circuits (India) Latest Developments
Table 109. Acotec Scientific Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 110. Acotec Scientific Drug-Coated Balloons Product Portfolios and Specifications
Table 111. Acotec Scientific Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Acotec Scientific Main Business
Table 113. Acotec Scientific Latest Developments
Table 114. AR Baltic Medical Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 115. AR Baltic Medical Drug-Coated Balloons Product Portfolios and Specifications
Table 116. AR Baltic Medical Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. AR Baltic Medical Main Business
Table 118. AR Baltic Medical Latest Developments
Table 119. Acrostak Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 120. Acrostak Drug-Coated Balloons Product Portfolios and Specifications
Table 121. Acrostak Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Acrostak Main Business
Table 123. Acrostak Latest Developments
Table 124. Biosensors International Group Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 125. Biosensors International Group Drug-Coated Balloons Product Portfolios and Specifications
Table 126. Biosensors International Group Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. Biosensors International Group Main Business
Table 128. Biosensors International Group Latest Developments
Table 129. BioMed Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 130. BioMed Drug-Coated Balloons Product Portfolios and Specifications
Table 131. BioMed Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. BioMed Main Business
Table 133. BioMed Latest Developments
Table 134. Concept Medical Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 135. Concept Medical Drug-Coated Balloons Product Portfolios and Specifications
Table 136. Concept Medical Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 137. Concept Medical Main Business
Table 138. Concept Medical Latest Developments
Table 139. Cardionovum Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 140. Cardionovum Drug-Coated Balloons Product Portfolios and Specifications
Table 141. Cardionovum Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 142. Cardionovum Main Business
Table 143. Cardionovum Latest Developments
Table 144. Endocor Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 145. Endocor Drug-Coated Balloons Product Portfolios and Specifications
Table 146. Endocor Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 147. Endocor Main Business
Table 148. Endocor Latest Developments
Table 149. Hexacath Sverige Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 150. Hexacath Sverige Drug-Coated Balloons Product Portfolios and Specifications
Table 151. Hexacath Sverige Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 152. Hexacath Sverige Main Business
Table 153. Hexacath Sverige Latest Developments
Table 154. iVascular SLU Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 155. iVascular SLU Drug-Coated Balloons Product Portfolios and Specifications
Table 156. iVascular SLU Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 157. iVascular SLU Main Business
Table 158. iVascular SLU Latest Developments
Table 159. Minvasys Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 160. Minvasys Drug-Coated Balloons Product Portfolios and Specifications
Table 161. Minvasys Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 162. Minvasys Main Business
Table 163. Minvasys Latest Developments
Table 164. MedAlliance Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 165. MedAlliance Drug-Coated Balloons Product Portfolios and Specifications
Table 166. MedAlliance Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 167. MedAlliance Main Business
Table 168. MedAlliance Latest Developments
Table 169. QT Vascular Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 170. QT Vascular Drug-Coated Balloons Product Portfolios and Specifications
Table 171. QT Vascular Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 172. QT Vascular Main Business
Table 173. QT Vascular Latest Developments
Table 174. RD Global-Invamed Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 175. RD Global-Invamed Drug-Coated Balloons Product Portfolios and Specifications
Table 176. RD Global-Invamed Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 177. RD Global-Invamed Main Business
Table 178. RD Global-Invamed Latest Developments
Table 179. SurModics Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 180. SurModics Drug-Coated Balloons Product Portfolios and Specifications
Table 181. SurModics Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 182. SurModics Main Business
Table 183. SurModics Latest Developments
Table 184. Terumo Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 185. Terumo Drug-Coated Balloons Product Portfolios and Specifications
Table 186. Terumo Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 187. Terumo Main Business
Table 188. Terumo Latest Developments
Table 189. Wellinq Basic Information, Drug-Coated Balloons Manufacturing Base, Sales Area and Its Competitors
Table 190. Wellinq Drug-Coated Balloons Product Portfolios and Specifications
Table 191. Wellinq Drug-Coated Balloons Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 192. Wellinq Main Business
Table 193. Wellinq Latest Developments
LIST OF FIGURES
Figure 1. Picture of Drug-Coated Balloons
Figure 2. Drug-Coated Balloons Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug-Coated Balloons Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Drug-Coated Balloons Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Drug-Coated Balloons Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of DCB for Peripheral Artery Disease
Figure 10. Product Picture of DCB for Coronary Artery Disease
Figure 11. Product Picture of DCB for Other Indications
Figure 12. Global Drug-Coated Balloons Sales Market Share by Type in 2023
Figure 13. Global Drug-Coated Balloons Revenue Market Share by Type (2019-2024)
Figure 14. Drug-Coated Balloons Consumed in Hospitals
Figure 15. Global Drug-Coated Balloons Market: Hospitals (2019-2024) & (K Units)
Figure 16. Drug-Coated Balloons Consumed in Cardiac Catheterization Labs
Figure 17. Global Drug-Coated Balloons Market: Cardiac Catheterization Labs (2019-2024) & (K Units)
Figure 18. Drug-Coated Balloons Consumed in ASCs
Figure 19. Global Drug-Coated Balloons Market: ASCs (2019-2024) & (K Units)
Figure 20. Global Drug-Coated Balloons Sales Market Share by Application (2023)
Figure 21. Global Drug-Coated Balloons Revenue Market Share by Application in 2023
Figure 22. Drug-Coated Balloons Sales Market by Company in 2023 (K Units)
Figure 23. Global Drug-Coated Balloons Sales Market Share by Company in 2023
Figure 24. Drug-Coated Balloons Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Drug-Coated Balloons Revenue Market Share by Company in 2023
Figure 26. Global Drug-Coated Balloons Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Drug-Coated Balloons Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Drug-Coated Balloons Sales 2019-2024 (K Units)
Figure 29. Americas Drug-Coated Balloons Revenue 2019-2024 ($ Millions)
Figure 30. APAC Drug-Coated Balloons Sales 2019-2024 (K Units)
Figure 31. APAC Drug-Coated Balloons Revenue 2019-2024 ($ Millions)
Figure 32. Europe Drug-Coated Balloons Sales 2019-2024 (K Units)
Figure 33. Europe Drug-Coated Balloons Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Drug-Coated Balloons Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Drug-Coated Balloons Revenue 2019-2024 ($ Millions)
Figure 36. Americas Drug-Coated Balloons Sales Market Share by Country in 2023
Figure 37. Americas Drug-Coated Balloons Revenue Market Share by Country in 2023
Figure 38. Americas Drug-Coated Balloons Sales Market Share by Type (2019-2024)
Figure 39. Americas Drug-Coated Balloons Sales Market Share by Application (2019-2024)
Figure 40. United States Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Drug-Coated Balloons Sales Market Share by Region in 2023
Figure 45. APAC Drug-Coated Balloons Revenue Market Share by Regions in 2023
Figure 46. APAC Drug-Coated Balloons Sales Market Share by Type (2019-2024)
Figure 47. APAC Drug-Coated Balloons Sales Market Share by Application (2019-2024)
Figure 48. China Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Drug-Coated Balloons Sales Market Share by Country in 2023
Figure 56. Europe Drug-Coated Balloons Revenue Market Share by Country in 2023
Figure 57. Europe Drug-Coated Balloons Sales Market Share by Type (2019-2024)
Figure 58. Europe Drug-Coated Balloons Sales Market Share by Application (2019-2024)
Figure 59. Germany Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Drug-Coated Balloons Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Drug-Coated Balloons Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Drug-Coated Balloons Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Drug-Coated Balloons Sales Market Share by Application (2019-2024)
Figure 68. Egypt Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Drug-Coated Balloons in 2023
Figure 74. Manufacturing Process Analysis of Drug-Coated Balloons
Figure 75. Industry Chain Structure of Drug-Coated Balloons
Figure 76. Channels of Distribution
Figure 77. Global Drug-Coated Balloons Sales Market Forecast by Region (2025-2030)
Figure 78. Global Drug-Coated Balloons Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Drug-Coated Balloons Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Drug-Coated Balloons Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Drug-Coated Balloons Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Drug-Coated Balloons Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Drug-Coated Balloons
Figure 2. Drug-Coated Balloons Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug-Coated Balloons Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Drug-Coated Balloons Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Drug-Coated Balloons Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of DCB for Peripheral Artery Disease
Figure 10. Product Picture of DCB for Coronary Artery Disease
Figure 11. Product Picture of DCB for Other Indications
Figure 12. Global Drug-Coated Balloons Sales Market Share by Type in 2023
Figure 13. Global Drug-Coated Balloons Revenue Market Share by Type (2019-2024)
Figure 14. Drug-Coated Balloons Consumed in Hospitals
Figure 15. Global Drug-Coated Balloons Market: Hospitals (2019-2024) & (K Units)
Figure 16. Drug-Coated Balloons Consumed in Cardiac Catheterization Labs
Figure 17. Global Drug-Coated Balloons Market: Cardiac Catheterization Labs (2019-2024) & (K Units)
Figure 18. Drug-Coated Balloons Consumed in ASCs
Figure 19. Global Drug-Coated Balloons Market: ASCs (2019-2024) & (K Units)
Figure 20. Global Drug-Coated Balloons Sales Market Share by Application (2023)
Figure 21. Global Drug-Coated Balloons Revenue Market Share by Application in 2023
Figure 22. Drug-Coated Balloons Sales Market by Company in 2023 (K Units)
Figure 23. Global Drug-Coated Balloons Sales Market Share by Company in 2023
Figure 24. Drug-Coated Balloons Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Drug-Coated Balloons Revenue Market Share by Company in 2023
Figure 26. Global Drug-Coated Balloons Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Drug-Coated Balloons Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Drug-Coated Balloons Sales 2019-2024 (K Units)
Figure 29. Americas Drug-Coated Balloons Revenue 2019-2024 ($ Millions)
Figure 30. APAC Drug-Coated Balloons Sales 2019-2024 (K Units)
Figure 31. APAC Drug-Coated Balloons Revenue 2019-2024 ($ Millions)
Figure 32. Europe Drug-Coated Balloons Sales 2019-2024 (K Units)
Figure 33. Europe Drug-Coated Balloons Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Drug-Coated Balloons Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Drug-Coated Balloons Revenue 2019-2024 ($ Millions)
Figure 36. Americas Drug-Coated Balloons Sales Market Share by Country in 2023
Figure 37. Americas Drug-Coated Balloons Revenue Market Share by Country in 2023
Figure 38. Americas Drug-Coated Balloons Sales Market Share by Type (2019-2024)
Figure 39. Americas Drug-Coated Balloons Sales Market Share by Application (2019-2024)
Figure 40. United States Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Drug-Coated Balloons Sales Market Share by Region in 2023
Figure 45. APAC Drug-Coated Balloons Revenue Market Share by Regions in 2023
Figure 46. APAC Drug-Coated Balloons Sales Market Share by Type (2019-2024)
Figure 47. APAC Drug-Coated Balloons Sales Market Share by Application (2019-2024)
Figure 48. China Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Drug-Coated Balloons Sales Market Share by Country in 2023
Figure 56. Europe Drug-Coated Balloons Revenue Market Share by Country in 2023
Figure 57. Europe Drug-Coated Balloons Sales Market Share by Type (2019-2024)
Figure 58. Europe Drug-Coated Balloons Sales Market Share by Application (2019-2024)
Figure 59. Germany Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Drug-Coated Balloons Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Drug-Coated Balloons Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Drug-Coated Balloons Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Drug-Coated Balloons Sales Market Share by Application (2019-2024)
Figure 68. Egypt Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Drug-Coated Balloons Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Drug-Coated Balloons in 2023
Figure 74. Manufacturing Process Analysis of Drug-Coated Balloons
Figure 75. Industry Chain Structure of Drug-Coated Balloons
Figure 76. Channels of Distribution
Figure 77. Global Drug-Coated Balloons Sales Market Forecast by Region (2025-2030)
Figure 78. Global Drug-Coated Balloons Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Drug-Coated Balloons Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Drug-Coated Balloons Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Drug-Coated Balloons Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Drug-Coated Balloons Revenue Market Share Forecast by Application (2025-2030)
